Senti Biosciences Holdings (SNTI) Treasury Shares (2021 - 2025)
Senti Biosciences Holdings (SNTI) posted quarterly Treasury Shares of $1.1 million for Q4 2025, up 5107.85% year-over-year from $21157.0 in Q4 2024, and up 5107.85% quarter-over-quarter from $21157.0 in Q4 2024.
Senti Biosciences Holdings (SNTI) Treasury Shares (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings' Treasury Shares history runs 5 years deep, the most recent figure standing at $1.1 million for Q4 2025.
- In Q4 2025, Treasury Shares rose 5107.85% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.1 million (up 5107.85% YoY), while the FY2025 annual figure was $1.1 million, up 1852.79% from the prior year.
- Treasury Shares for Q4 2025 stood at $1.1 million, up from $21157.0 in the prior quarter.
- The five-year high for Treasury Shares was $19.5 million in Q2 2021, with the low at $21157.0 in Q4 2024.
- The 5-year median for Treasury Shares is $15.7 million (2021), against an average of $12.2 million.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares jumped 65.21% in 2022, then surged 5107.85% in 2025.
- Senti Biosciences Holdings' Treasury Shares stood at $19.5 million in 2021, then changed by 0.0% to $19.5 million in 2022, then tumbled by 66.7% to $6.5 million in 2023, then tumbled by 99.67% to $21157.0 in 2024, then soared by 5107.85% to $1.1 million in 2025.
- Business Quant data shows SNTI's Treasury Shares at $1.1 million in Q4 2025, $21157.0 in Q4 2024, and $6.5 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Senti Biosciences Holdings | 12.06 Mn | 12.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 21,157.00 |
| Dec 31, 2024 | 21,157.00 |
| Sep 30, 2023 | 6.50 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Mar 31, 2022 | 19.52 Mn |
| Mar 31, 2022 | 19.52 Mn |
| Dec 31, 2021 | 19.52 Mn |
| Dec 31, 2021 | 19.52 Mn |
| Sep 30, 2021 | 19.52 Mn |
| Sep 30, 2021 | 19.52 Mn |
| Jun 30, 2021 | 19.52 Mn |
| Jun 30, 2021 | 19.52 Mn |
| Mar 31, 2021 | 11.81 Mn |
| Mar 31, 2021 | 11.81 Mn |